A who's who of integrity agreements

Share this article:

FDA anger can bring down a corporate integrity agreement on a drug or device maker. Health and Human Services' Office of the Inspector General has a lineup of the pharma companies who are on notice. Of the 20 listed, only one has an end date or has been closed (congratulations, Medtronic).

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.